Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...

Gastritis-II: Pathophysiology

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Nobel Prize honours the discovery of the natural barrier against autoimmunity - a breakthrough in tolerance reconstitution: how far are we from clinical impact?

EULAR rheumatology open·2026

Same author

BCMA-directed therapy with cizutamig induces rapid improvement in long-standing systemic sclerosis-associated interstitial lung disease.

Rheumatology (Oxford, England)·2026

Same author

Tocilizumab but not Siltuximab prevents systemic inflammation in a humanized mouse model.

Frontiers in immunology·2026

Same author

Teclistamab for treatment-refractory autoimmune diseases: a multicentre case series.

Annals of the rheumatic diseases·2026

Same author

Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis-a case series.

Annals of the rheumatic diseases·2026

Same author

Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study From the EUSTAR Cohort.

Arthritis care & research·2026

Same journal

The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies.

Seminars in immunopathology·2026

Same journal

The complex of gut microbial metabolites and sex hormones in Alzheimer's disease.

Seminars in immunopathology·2026

Same journal

Endometrial pathophysiology and pregnancy: from mechanism to intervention.

Seminars in immunopathology·2026

Same journal

Advances in understanding the dual roles of testicular immune responses: From immune privilege to inflammation.

Seminars in immunopathology·2026

Same journal

Climate change-associated heat extremes and immune dysregulation: emerging links with autoimmunity, allergy, and infectious diseases.

Seminars in immunopathology·2026

Same journal

The cancer-microbiome axis: Mechanisms and emerging therapeutic strategies.

Seminars in immunopathology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 5, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

Functional autoantibodies in systemic sclerosis.

Jeannine Günther¹, Judith Rademacher, Jakob M van Laar

¹Department of Rheumatology and Clinical Immunology, University Hospital Charité, Berlin, Germany, guenther@drfz.de.

Seminars in Immunopathology

|August 22, 2015

Summary

This summary is machine-generated.

Functional autoantibodies are immunoglobulins that stimulate or inhibit target proteins, driving organ damage in autoimmune disorders like systemic sclerosis. Distinguishing them from non-functional autoantibodies is crucial for developing new therapies.

More Related Videos

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

Related Experiment Videos

Last Updated: Apr 5, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

Area of Science:

Immunology
Autoimmunity
Molecular Biology

Background:

Autoantibodies have long been recognized in autoimmune disorders.
Emerging research highlights the functional impact of specific autoantibodies.
Functional autoantibodies bind target molecules, influencing cellular processes.

Purpose of the Study:

To differentiate functional autoantibodies from non-functional ones based on their molecular interactions.
To underscore the pathogenic role of functional autoantibodies in autoimmune diseases.
To explore therapeutic implications of understanding functional autoantibody mechanisms.

Main Methods:

Review of existing literature on autoantibody targets and binding mechanisms.
Analysis of downstream effects mediated by functional autoantibodies.
Comparison of functional and non-functional autoantibody characteristics.

Main Results:

Functional autoantibodies can stimulate or inhibit target proteins.
These antibodies are implicated as pathogenic drivers in organ-specific damage.
Systemic sclerosis serves as a key example of functional autoantibody-mediated pathology.

Conclusions:

Distinguishing functional from non-functional autoantibodies is essential.
Functional autoantibodies play a significant role in autoimmune disease pathogenesis.
Understanding these mechanisms opens avenues for novel therapeutic strategies.